| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $31.43 ▲ +4.49% | Yesterday | $31.36 ▼ -4.08% | Tomorrow's Stoke Therapeutics Inc. Common Stock (STOK) setup is anchored to $30.08 and targets $31.43 (+4.49%). The near-term read is upside; watch $30.74 / $29.48 because daily realized volatility is about 2.29%. |
Tomorrow's Stoke Therapeutics Inc. Common Stock (STOK) setup is anchored to $30.08 and targets $31.43 (+4.49%). The near-term read is upside; watch $30.74 / $29.48 because daily realized volatility is about 2.29%. | ||||
| Week | $32.94 ▲ +9.51% | Last Week | $32.89 ▼ -8.54% | The 7-day Stoke Therapeutics Inc. Common Stock model moves from $32.89 to $32.94 (+9.51%). It gives upside momentum context for this stock, so breaks around $30.74 / $29.48 matter more than a single tick. |
The 7-day Stoke Therapeutics Inc. Common Stock model moves from $32.89 to $32.94 (+9.51%). It gives upside momentum context for this stock, so breaks around $30.74 / $29.48 matter more than a single tick. | ||||
| Month | $32.88 ▲ +9.31% | Last Month | $37.27 ▼ -19.29% | The 1-month Stoke Therapeutics Inc. Common Stock target is $32.88 (+9.31%), compared with the live reference near $30.08. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Stoke Therapeutics Inc. Common Stock target is $32.88 (+9.31%), compared with the live reference near $30.08. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $31.12 ▲ +3.46% | Last Year | $9.76 ▲ +208.20% | The 1-year Stoke Therapeutics Inc. Common Stock scenario points to $31.12 (+3.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Stoke Therapeutics Inc. Common Stock scenario points to $31.12 (+3.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $26.50 ▼ -11.90% | 5 Years Ago | $34.65 ▼ -13.19% | The 5-year Stoke Therapeutics Inc. Common Stock view is $26.50 (-11.90%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Stoke Therapeutics Inc. Common Stock view is $26.50 (-11.90%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 61.9 | Bullish |
| MACD | 0.10 | Bullish |
| SMA 50 | $31.88 | Mid |
| SMA 200 | $30.33 | Mid |
| EMA 20 | $31.82 | Mid |
| Opening Price | $31.04 | Start Date | 2020-01-02 |
| Day Range | $29.70 – $31.04 | Market Cap | $2.11B |
| Monthly Range | $30.08 – $37.27 | 24h Volume | n/a |
| 90D Range | $28.70 – $38.35 | Circulating | n/a |
| 52W Range | $5.90 – $38.35 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.